Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth

Nature Medicine

Volumn 3, Issue 8, 1997, Pages 887-893

  Wang, Yiping ^a   Becker, Dorothea ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR RECEPTOR; MESSENGER RNA;

ANGIOGENESIS; ARTICLE; CANCER INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; CELL DIVISION; DNA, COMPLEMENTARY; FIBROBLAST GROWTH FACTOR 2; GENE TRANSFER TECHNIQUES; HUMANS; MELANOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 0030855812     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0897-887     Document Type: Article

References (36)

1. Marincola, F.M. & Rosenberg, S.A. Biologic therapy with interleukin-2: Preclinical studies. in: Biologic Therapy of Cancer. (eds. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) 250-262 (Lippincott, Philadelphia, 1995).
2. Kirkwood, J.M. Biologic therapy with interferon-α and β: Clinical applications. in: Biologic Therapy of Cancer. (eds. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) 388-411 (Lippincott, Philadelphia, 1995).
3. Houghton, A.N. & Chapman, P.B. Clinical applications of monoclonal antibodies in cancer. in: Biologic Therapy of Cancer. (eds. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) 576-590 (Lippincott, Philadelphia, 1995).
4. Van Der Bruggen, P. et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647 (1991).
5. Halaban, R., Kwon, B.S., Ghosh, S., Delli-Bovi, P. & Baird, A. bFGF as an autocrine growth factor for human melanomas. Oncogene Res. 3, 177-186 (1988).
6. Becker, D., Meier, C.B. & Herlyn, M. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J. 8, 3685-3691 (1989).
7. Becker, D., Lee, P.L., Rodeck, U. & Herlyn, M. Inhibition of the fibroblast growth factor receptor 1 (FGFR-I ) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene 7, 2302-2313 (1992).
8. Abraham, J.A. et al. Human basic fibroblast growth factor: Nucleotide sequence and genomic organization. EMBO J. 5, 2523-2528 (1986).
9. Johnson, D.E., Lee, P.L., Lu, J. & Williams, L.T. Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol. Cell. Biol. 10, 4728-4739 (1990).
10. Johnson, D.E., Lu, J., Chen, S., Werner, S. & Williams, L.T. The human fibroblast growth factor genes: A common structural arrangement underlies the mechanism for generating receptors that differ in their third immunoglobulin domain. Mol. Cell. Biol. 11, 4627-4634 (1991).
11. Vignovich, J. & Becker, D. Expression of bFGF and differential expression of FGF receptors in normal human myoblasts and rhabdomyosarcomas. Int. J. Oncol. 2, 637-642 (1993).
12. Gao, X. & Huang, L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179, 280-285 (1991).
13. Yang, J.-P. & Huang, L. Direct gene transfer to mouse melanoma by intratumor injection of free DNA. Gene Ther. 3, 542-547 (1996).
14. Nabel, G.J. et al. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90, 11307-11311 (1993).
15. Werner, S. et al. Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J. 12, 2635-2643 (1993).
16. Nickoloff, R.J. PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi's sarcoma. J. Clin. Pathl. 43, 752-757(1993).
17. Sehested, M. & Hou-Jensen, K. Factor VIII-related antigen as an endothelial cell marker in benign and malignant diseases. Virchows Arch. 391, 217-225 (1981).
18. Ledbetter, J.A. & Herzenberg, L.A. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47, 63-67 (1979).
19. Herlyn, M., Mancianti, M.L., Jambrosic, J., Bolen, J.B. & Koprowski, H. Regulatory factors that determine growth and phenotype of normal human melanocytes. Exp. Cell Res. 179, 322-331 (1988).
20. Rodeck, U. et al. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J. Invest. Dermatol. 97, 20-26 (1991).
21. Dionne, C.A. et al. Cloning and expression of two distinct high affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9, 2685-2692 (1990).
22. Keegan, K., Johnson, D.E., Williams, L.T. & Hayman, M.J. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc. Natl. Acad. Sci. USA 88, 1095-1099 (1991).
23. Partanen, J. et al. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 10, 1347-1354 (1991).
24. Ferrara, N., Houck, K.A., Jakeman, L.B., Winer, j. & Leung, D.W. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47, 211-218 (1991).
25. Folkman, J. Tumor angiogenesis. in: The Molecular Basis of Cancer. (eds. Mendelsohn, J., Howley, P.M., M., Israel, M.A. & Liotta, L.A.) 206-232 (Saunders, Philadelphia, 1995).
26. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996).
27. Wang, Y. et al. Molecular analysis of melanoma precursor lesions. Cell Growth Differ. 7, 1733-1740 (1996).
28. Elder, D.E., Clark, W.H., Jr., Glenitsas, R., Guerry, D., IV & Halpern, A.C. The early and intermediate precursor lesions of tumor progression in the melanocytic system: Common acquired nevi and atypical (dysplastic) nevi. Semin. Diagn. Pathol. 10, 18-35 (1993).
29. Parangi, S. et al. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. USA 93, 2002-2007 (1996).
30. Singh, R.K. et al. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl. Acad. Sci. USA 92, 4562-4566 (1995).
31. Brooks, P.C., Clark, R.A.F. & Cheresh, D.A. Requirement of vascular integrin αυβ3 for angiogenesis. Science 264, 569-57 (1994).
32. Brooks, P.C. et al. Integrin αυβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164 (1994).
33. Montgomery, A.M.P., Reisfeld, R.A. & Cheresh, D.A. Integrin αυβ3 rescues melanoma cells from apoptosis in a three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA 91, 8856-8860 (1994).
34. Herlyn, M. et al. Biology of tumor progression in human melanocytes. Lab. Invest. 56, 461-474 (1987).
35. Walgenbach, K.J., Gratas, C., Shestak, K.C, & Becker, D. Ischaemia-induced expression of bFGF in normal skeletal muscle: A potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle. Nature Med. 1, 453-459 (1995).
36. Gaynor, E., lrie, R., Morton, D. & Herschman, H.R. S100 protein is present in cultured human malignant melanomas. Nature 286, 400-401 (1980).